Details of the Active Pharmaceutical Ingredient (API)
General Information of API (ID: D00727) | |||||
---|---|---|---|---|---|
Name |
Vigabatrin
|
||||
Synonyms |
Click to Show/Hide the Synonyms of This API
vigabatrin; 4-aminohex-5-enoic acid; Sabril; 60643-86-9; 68506-86-5; Vigabatrine; gamma-Vinyl GABA; 4-Amino-5-hexenoic acid; gamma-Vinyl-GABA; 5-Hexenoic acid, 4-amino-; Vigabatrinum; 4-Aminohexenoic acid; gamma-Vinyl-gamma-Aminobutyric Acid; MDL-71754; RMI-71754; CPP-109; CPP109; (+/-)-Vigabatrin; (R,S)-4-Amino-5-hexenoic acid; MDL 71,754; 4-Amino-hex-5-enoic acid; (+/-)-gamma-Vinyl-GABA; CHEMBL89598; CHEBI:63638; Vigabatrine [French]; Vigabatrinum [Latin]; Vigabatrina [Spanish]; VINYL GAMMA-AMINOBUTYRIC ACID; MFCD00274577; NCGC00016087-06; Vigabatrina; Sabrilex; 4-aminohex-5-enoic acid/S(+)-Gamma-VIGABATRIN; gamma Vinyl GABA; Sabril (TN); (4R)-4-aminohex-5-enoic acid; (4S)-4-aminohex-5-enoic acid; Vigabatrin [USAN:INN:BAN]; MDL 71754; RMI 71754; Hexenoic acid, 4-amino; SR-01000075653; (S)-4-Amino-5-hexenoic Acid; (+-)-gamma-Vinyl GABA; Kigabeq; MFCD00274076; (1)-4-Aminohex-5-enoic acid; CPP 109; Vigabatrin solution; Prestwick_837; EINECS 270-929-6; CAS-60643-86-9; RMI-71890; .gamma.-vinyl GABA; .gamma.-Vinyl-GABA; Spectrum_000368; SpecPlus_000664; (y)-gamma-Vinyl GABA; Prestwick0_000501; Prestwick1_000501; Prestwick2_000501; Prestwick3_000501; Spectrum3_001825; (?)-gamma-Vinyl GABA; Biomol-NT_000247; V 8261; DSSTox_CID_21153; DSSTox_RID_79637; DSSTox_GSID_41153; Lopac0_001277; M071754; SCHEMBL26714; (+/-)-gamma-Vinyl GABA; BSPBio_000421; BSPBio_003469; KBioSS_000848; Vigabatrin (JAN/USP/INN); (A+/-)-gamma-Vinyl GABA; DivK1c_006760; SPECTRUM1502036; (+/-)-?-Vinyl GABA; SPBio_002342; (+/-)-4-Aminohexenoic acid; BPBio1_000465; BPBio1_000925; GTPL4821; DTXSID4041153; Vinyl .gamma.-aminobutyric Acid; HSDB 8395; KBio1_001704; KBio2_000848; KBio2_003416; KBio2_005984; KBio3_002973; AOB6800; S(+)-4-AMINOHEXENOICACID; HMS1569F03; HMS2094M21; HMS2096F03; HMS3263P16; (plusmn)-4-aminohex-5-enoic acid; BCP16220; Tox21_110301; Tox21_501277; BDBM50118886; AKOS015854596; ACN-036276; CCG-205350; CS-0791; DB01080; LP01277; SDCCGSBI-0051243.P004; (?)-4-AMINOHEX-5-ENOIC ACID; .gamma.-Vinyl-.gamma.-aminobutyric acid; NCGC00016087-03; NCGC00016087-04; NCGC00016087-05; NCGC00016087-07; NCGC00016087-08; NCGC00016087-09; NCGC00016087-11; NCGC00016087-22; NCGC00024802-02; NCGC00024802-03; NCGC00024802-04; NCGC00024802-05; NCGC00024802-06; NCGC00261962-01; AS-11778; HY-15399; SY263247; SBI-0051243.P003; ( inverted question mark)-gamma-Vinyl GABA; AB0010729; DB-117820; AB00053309; EU-0101277; FT-0675811; FT-0675812; FT-0700968; C07500; D00535; W-5102; AB00053309_04; Q421663; Q-201924; SR-01000075653-1; SR-01000075653-4; SR-01000075653-6; ( inverted exclamation markA)-4-aminohex-5-enoic acid; BRD-A07893380-001-01-6; Z2235791448; Vigabatrin, European Pharmacopoeia (EP) Reference Standard; Vigabatrin, United States Pharmacopeia (USP) Reference Standard
|
||||
Clinical Status |
Approved
|
||||
Disease Indication | Lennox-gastaut syndrome | ICD-11: 8A62 | [1] | ||
PubChem CID | |||||
Formula |
C6H11NO2
|
||||
Canonical SMILES |
C=CC(CCC(=O)O)N
|
||||
InChI |
1S/C6H11NO2/c1-2-5(7)3-4-6(8)9/h2,5H,1,3-4,7H2,(H,8,9)
|
||||
InChIKey |
PJDFLNIOAUIZSL-UHFFFAOYSA-N
|
||||
Click to Show/Hide the Molecular Data (Structure/Property) of This API | |||||
Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=5665"></iframe>
|
||||
3D MOL | 2D MOL | ||||
Physicochemical Properties | Molecular Weight | 129.16 | Topological Polar Surface Area | 63.3 | |
XlogP | -2.2 | Complexity | 112 | ||
Heavy Atom Count | 9 | Rotatable Bond Count | 4 | ||
Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 3 | ||
Full List of Drug Formulations (DFMs) Containing This API | ||||||
---|---|---|---|---|---|---|
Vigabatrin 500 mg tablet | Click to Show/Hide the Full List of Formulation(s): 1 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Titanium dioxide; Povidone; Cellulose, microcrystalline; Hypromelloses; Polyethylene glycols; Sodium starch glycolate type a potato
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Lundbeck Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.